Collection of Safety and Performance Data for BIOTRONIK EP Devices in Cardiac Arrhythmia Procedures

What this Trial Is About

Researchers are collecting data to evaluate the safety, performance, and clinical benefits of BIOTRONIKs electrophysiology EP products used in patients with cardiac arrhythmias. This observational, international study aims to support regulatory requirements and maintain approval for these devices in the European CE region by monitoring risks during and after procedures. Participants will undergo diagnostic or therapeutic catheter interventions using BIOTRONIK EP products, which include catheters, external devices like RF generators and pacemakers, and transseptal sheaths. These devices are used temporarily during electrophysiology studies or catheter ablation procedures. The study does not involve randomization or blinding and follows patients through their routine care. During the study, researchers will collect data on device deficiencies and adverse effects during the EP procedure, within 24 hours afterward, and up to 3 to 6 months post-procedure. Clinical benefits will be confirmed at the time of the procedure. Participants are expected to attend follow-up visits at the study site, and data collection will continue until mid-2030 to assess device safety and performance over time.

Post-market Clinical Follow-up Data Collection From Procedures With BIOTRONIK EP Products